Rajavelu Esther
Chief Executive Officer, Chief Financial Officer and Chief Business Officer
CIK: 1903716
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 4, 2026 | Spero Therapeutics, Inc. (SPRO) | S | 25,240 | $2.51 | $63,352.40 | View Details Filing |